IPP Bureau
Molnupiravir, a step closer to approval in the fight against Covid-19
By IPP Bureau - December 02, 2021
The U.S. FDA advisory committee voted 13-10 in favour of the oral antiviral medicine
Sai Life Sciences receive Certificate of Inspection from Japan PMDA
By IPP Bureau - December 02, 2021
The company has also started working with a large pharma company on the API supply of a recently launched animal and human health product
Premas Biotech and Oravax to test their vaccine candidate against Omicron
By IPP Bureau - December 02, 2021
Oravax's vaccine technology is highly scalable for manufacturing and is easily transferable for wide scale logistical distribution, as there is no need for freezer storage
Amrutanjan Health Care opens first store in Chennai
By IPP Bureau - December 02, 2021
The offline store launch will complement the E-commerce website in building a rich consumer shopping experience
Sanofi to acquire Origimm Biotechnology to treat acne with vaccine
By IPP Bureau - December 02, 2021
Transaction adds to Sanofi pipeline a potential first-in-class vaccine candidate in acne vulgaris, a condition affecting millions of people worldwide
Lupin partners with TTP for soft-mist inhalation tech platform
By IPP Bureau - December 02, 2021
Soft-mist inhalation (SMI) technology allows for delivery of inhalation drugs from a small, portable hand-held inhaler device without the use of propellants
GSK's antibody drug sotrovimab works against Omicron mutations
By IPP Bureau - December 02, 2021
Preclinical data demonstrate sotrovimab, authorised in multiple countries around the world, retains activity against all tested variants of concern, including key mutations of Omicron
ZyCoV-D to be initially administered in seven states
By IPP Bureau - December 02, 2021
The three doses of ZyCoV-D are to be administered 28 days apart. The vaccine was given emergency use authorisation (EUA) by the Indian drug regulator on August 20
LifeCell Diagnostics introduces the NovaSeq 6000
By IPP Bureau - December 02, 2021
One of the very few facilities in India to have this capability, marking a remarkable feat in LifeCell’s expedition to take genome sequencing to the next level in India
Sygnature Discovery appoints Louisa Jordison as Chief Financial Officer
By IPP Bureau - December 01, 2021
She replaces Victoria Tabiner, who is stepping down after 10 years at Sygnature
Jaslok Hospital launches heart transplant programme in Mumbai
By IPP Bureau - December 01, 2021
The country’s top heart transplant surgeon Dr. K.R Balakrishnan to be leading the programme for Jaslok
Roche completes acquisition of TIB Molbiol
By IPP Bureau - December 01, 2021
TIB Molbiol excels in ultra-rapid assay development for emerging infectious diseases, strongly demonstrated during the Covid-19 pandemic
Anaemia due to iron deficiency is a cause for concern in India
By IPP Bureau - December 01, 2021
According to a survey conducted by FOGSI last year, 92% of the doctors opined that anaemia due to iron deficiency can be eradicated in five years
P&G Health commemorates Iron Deficiency Day with a new Guinness World Records
By IPP Bureau - November 30, 2021
Records the largest number of videos of people saying the same sentence uploaded to Facebook in one hour to raise awareness on Iron Deficiency Anaemia
U.S. FDA accepts Bristol Myers Squibb’s application for Deucravacitinib
By IPP Bureau - November 30, 2021
Applications supported by positive results from the pivotal Phase 3 POETYK-PSO clinical trial program demonstrating superior efficacy of deucravacitinib over Otezla (apremilast)
